Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
Environ Health Perspect ; 125(9): 097005, 2017 09 07.
Article in English | MEDLINE | ID: mdl-28934722

ABSTRACT

BACKGROUND: Rice contains arsenic, a known skin carcinogen. Rice intake has been associated with arsenic-related skin lesions in South Asia, but its association with skin cancers is as yet unknown. OBJECTIVES: We aimed to investigate whether rice intake contributes to urinary arsenic concentration and risk of squamous cell carcinoma (SCC) of the skin in a U.S. population. METHODS: Rice consumption was assessed using a food frequency questionnaire administered as part of a population-based case-control study of 487 SCC cases and 462 age- and gender-matched controls. Arsenic concentration in household tap water and urine samples were measured using inductively coupled mass spectrometry (ICP-MS) and high-resolution ICP-MS, respectively. Odds ratios (OR) for SCC associated with the frequency of rice consumption were estimated using logistic regression, with adjustment for age, gender, and caloric intake. RESULTS: Those who reported any rice consumption had higher urinary arsenic concentrations than those who did not consume rice, and the association was most pronounced among those with <1µg/L arsenic in their household water (19.2% increase in total urinary arsenic, 95% CI: 5.0, 35.3%). Any rice consumption was associated with a 1.5-fold (95% CI: 1.1, 2.0) higher odds of SCC compared with those who reported no rice consumption, and the relation appeared to be largely among those with <1µg/L water arsenic. CONCLUSION: Rice consumption may be related to the occurrence of SCC in the United States, especially among those with relatively low drinking water arsenic exposure. https://doi.org/10.1289/EHP1065.


Subject(s)
Arsenic/urine , Carcinoma, Squamous Cell/epidemiology , Diet/statistics & numerical data , Environmental Exposure/statistics & numerical data , Environmental Pollutants/urine , Food Contamination/statistics & numerical data , Oryza , Skin Neoplasms/epidemiology , Case-Control Studies , Female , Humans , Logistic Models , Male , Odds Ratio , United States/epidemiology
2.
Toxicol Appl Pharmacol ; 287(2): 93-97, 2015 Sep 01.
Article in English | MEDLINE | ID: mdl-26048586

ABSTRACT

High levels of arsenic exposure have been associated with increases in cardiovascular disease risk. However, studies of arsenic's effects at lower exposure levels are limited and few prospective studies exist in the United States using long-term arsenic exposure biomarkers. We conducted a prospective analysis of the association between toenail arsenic and cardiovascular disease mortality using longitudinal data collected on 3939 participants in the New Hampshire Skin Cancer Study. Using Cox proportional hazard models adjusted for potential confounders, we estimated hazard ratios and 95% confidence intervals associated with the risk of death from any cardiovascular disease, ischemic heart disease, and stroke, in relation to natural-log transformed toenail arsenic concentrations. In this US population, although we observed no overall association, arsenic exposure measured from toenail clipping samples was related to an increased risk of ischemic heart disease mortality among long-term smokers (as reported at baseline), with increased hazard ratios among individuals with ≥ 31 total smoking years (HR: 1.52, 95% CI: 1.02, 2.27), ≥ 30 pack-years (HR: 1.66, 95% CI: 1.12, 2.45), and among current smokers (HR: 1.69, 95% CI: 1.04, 2.75). These results are consistent with evidence from more highly exposed populations suggesting a synergistic relationship between arsenic exposure and smoking on health outcomes and support a role for lower-level arsenic exposure in ischemic heart disease mortality.


Subject(s)
Arsenic/analysis , Cardiovascular Diseases/mortality , Environmental Exposure/analysis , Nails/chemistry , Smoking/epidemiology , Adult , Aged , Biomarkers , Cardiovascular Diseases/epidemiology , Female , Humans , Longitudinal Studies , Male , Middle Aged , Myocardial Ischemia/mortality , Prospective Studies , Risk Factors , Skin Neoplasms/epidemiology , Socioeconomic Factors , United States
3.
Cancer Epidemiol Biomarkers Prev ; 24(4): 749-54, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25670807

ABSTRACT

BACKGROUND: Little is known about whether history of allergies and atopy is related to the occurrence of keratinocyte cancers. Thus, we evaluated the association between history of allergies and atopy and the incidence of squamous cell carcinoma (SCC) and early onset basal cell carcinoma (BCC). METHODS: As part of a population-based case-control study, interviews were conducted with 1,050 residents of New Hampshire (375 early onset BCC cases and 251 controls, 254 SCC cases and 432 controls). ORs of SCC and early onset BCC and history of allergy and atopic dermatitis were computed using logistic regression, while controlling for potential confounding factors. RESULTS: An overall inverse association was observed between a history of allergy and early onset BCC [OR, 0.61; 95% confidence interval (CI), 0.38-0.97] but not SCC (OR, 1.18; 95% CI, 0.78-1.79). Among women, we found reduced ORs of both early onset BCC and of SCC in relation to allergy history (early onset BCC OR, 0.53; 95% CI, 0.31-0.92 and SCC OR, 0.59; 95% CI, 0.29-1.19). Among men, we observed no clear association with early onset BCC (OR, 0.87; 95% CI, 0.39-1.99) and an increased risk of SCC (OR, 1.58; 95% CI, 0.93-2.69). CONCLUSION: Our findings suggest that allergies and atopy may influence risk of early onset BCC and SCC, and that effects may be gender specific. IMPACT: A deeper understanding of the immune mechanisms underlying allergies and atopy may provide new routes of preventing keratinocyte cancers.


Subject(s)
Carcinoma, Basal Cell/epidemiology , Carcinoma, Squamous Cell/epidemiology , Dermatitis, Atopic/epidemiology , Hypersensitivity/epidemiology , Skin Neoplasms/epidemiology , Adult , Aged , Carcinoma, Basal Cell/etiology , Carcinoma, Squamous Cell/etiology , Case-Control Studies , Female , Humans , Incidence , Male , Middle Aged , Sex Factors
4.
Int J Cancer ; 137(4): 878-884, 2015 Aug 15.
Article in English | MEDLINE | ID: mdl-25598534

ABSTRACT

A retrospective cohort analysis of survival after keratinocyte cancer (KC) was conducted using data from a large, population-based case-control study of KC in New Hampshire. The original study collected detailed information during personal interviews between 1993 and 2002 from individuals with squamous (SCC) and basal (BCC) cell carcinoma, and controls identified through the Department of Transportation, frequency-matched on age and sex. Participants without a history of non-skin cancer at enrolment were followed as a retrospective cohort to assess survival after either SCC or BCC, or a reference date for controls. Through 2009, cancers were identified from the New Hampshire State Cancer Registry and self-report; death information was obtained from state death certificate files and the National Death Index. There were significant differences in survival between those with SCC, BCC and controls (p = 0.040), with significantly greater risk of mortality after SCC compared to controls (adjusted hazard ratio [HR] 1.25; 95% confidence interval 1.01-1.54). Mortality after BCC was not significantly altered (HR 0.96; 95% CI 0.77-1.19). The excess mortality after SCC persisted after adjustment for numerous personal risk factors including time-varying non-skin cancer occurrence, age, sex and smoking. Survival from the date of the intervening cancer, however, did not vary (HR for SCC 0.98; 95% CI 0.70-1.38). Mortality also remained elevated when individuals with subsequent melanoma were excluded (HR for SCC 1.30; 95% CI 1.05-1.61). Increased mortality after SCC cannot be explained by the occurrence of intervening cancers, but may reflect a more general predisposition to life threatening illness that merits further investigation.


Subject(s)
Carcinoma, Basal Cell/mortality , Carcinoma, Squamous Cell/mortality , Skin Neoplasms/mortality , Carcinoma, Basal Cell/pathology , Carcinoma, Squamous Cell/pathology , Female , Follow-Up Studies , Humans , Male , Neoplasm Staging , Skin Neoplasms/pathology , Survival Analysis
5.
Pediatrics ; 134(1): e4-12, 2014 Jul.
Article in English | MEDLINE | ID: mdl-24958589

ABSTRACT

OBJECTIVE: Indoor tanning with UV radiation-emitting lamps is common among adolescents and young adults. Rising incidence rates of basal cell carcinoma (BCC) have been reported for the United States and elsewhere, particularly among those diagnosed at younger ages. Recent epidemiologic studies have raised concerns that indoor tanning may be contributing to early occurrence of BCC, and younger people may be especially vulnerable to cancer risk associated with this exposure. Therefore, we sought to address these issues in a population-based case-control study from New Hampshire. METHODS: Data on indoor tanning were obtained on 657 cases of BCC and 452 controls ≤50 years of age. RESULTS: Early-onset BCC was related to indoor tanning, with an adjusted odds ratio (OR) of 1.6 (95% confidence interval, 1.3-2.1). The strongest association was observed for first exposure as an adolescent or young adult, with a 10% increase in the OR with each age younger at first exposure (OR per year of age ≤23 = 1.1; 95% confidence interval, 1.0-1.2). Associations were present for each type of device examined (ie, sunlamps, tanning beds, and tanning booths). CONCLUSIONS: Our findings suggest early exposure to indoor tanning increases the risk of early development of BCC. They also underscore the importance of counseling adolescents and young adults about the risks of indoor tanning and for discouraging parents from consenting minors to this practice.


Subject(s)
Beauty Culture , Carcinoma, Basal Cell/epidemiology , Carcinoma, Basal Cell/etiology , Skin Neoplasms/epidemiology , Skin Neoplasms/etiology , Ultraviolet Rays/adverse effects , Adult , Age Factors , Case-Control Studies , Female , Humans , Incidence , Male , Middle Aged
6.
PLoS One ; 9(6): e99674, 2014.
Article in English | MEDLINE | ID: mdl-24937304

ABSTRACT

INTRODUCTION: Several studies have shown an increased risk of cancer after non melanoma skin cancers (NMSC) but the individual risk factors underlying this risk have not been elucidated, especially in relation to sun exposure and skin sensitivity to sunlight. PURPOSE: The aim of this study was to examine the individual risk factors associated with the development of subsequent cancers after non melanoma skin cancer. METHODS: Participants in the population-based New Hampshire Skin Cancer Study provided detailed risk factor data, and subsequent cancers were identified via linkage with the state cancer registry. Deaths were identified via state and national death records. A Cox proportional hazard model was used to estimate risk of subsequent malignancies in NMSC patients versus controls and to assess the potential confounding effects of multiple risk factors on this risk. RESULTS: Among 3584 participants, risk of a subsequent cancer (other than NMSC) was higher after basal cell carcinoma (BCC) (adjusted HR 1.40 [95% CI 1.15, 1.71]) than squamous cell carcinoma (SCC) (adjusted HR 1.18 [95% CI 0.95, 1.46]) compared to controls (adjusted for age, sex and current cigarette smoking). After SCC, risk was higher among those diagnosed before age 60 (HR 1.96 [95% CI 1.24, 3.12]). An over 3-fold risk of melanoma after SCC (HR 3.62; 95% CI 1.85, 7.11) and BCC (HR 3.28; 95% CI 1.66, 6.51) was observed, even after further adjustment for sun exposure-related factors and family history of skin cancer. In men, prostate cancer incidence was higher after BCC compared to controls (HR 1.64; 95% CI 1.10, 2.46). CONCLUSIONS: Our population-based study indicates an increased cancer risk after NMSC that cannot be fully explained by known cancer risk factors.


Subject(s)
Carcinoma, Basal Cell/epidemiology , Carcinoma, Squamous Cell/epidemiology , Melanoma/epidemiology , Neoplasms, Second Primary/epidemiology , Skin Neoplasms/epidemiology , Case-Control Studies , Female , Follow-Up Studies , Humans , Male , Proportional Hazards Models , Risk
7.
Nutr J ; 12: 149, 2013 Nov 16.
Article in English | MEDLINE | ID: mdl-24237880

ABSTRACT

BACKGROUND: Limited data exist on the contribution of dietary sources of arsenic to an individual's total exposure, particularly in populations with exposure via drinking water. Here, the association between diet and toenail arsenic concentrations (a long-term biomarker of exposure) was evaluated for individuals with measured household tap water arsenic. Foods known to be high in arsenic, including rice and seafood, were of particular interest. METHODS: Associations between toenail arsenic and consumption of 120 individual diet items were quantified using general linear models that also accounted for household tap water arsenic and potentially confounding factors (e.g., age, caloric intake, sex, smoking) (n = 852). As part of the analysis, we assessed whether associations between log-transformed toenail arsenic and each diet item differed between subjects with household drinking water arsenic concentrations <1 µg/L versus ≥1 µg/L. RESULTS: As expected, toenail arsenic concentrations increased with household water arsenic concentrations. Among the foods known to be high in arsenic, no clear relationship between toenail arsenic and rice consumption was detected, but there was a positive association with consumption of dark meat fish, a category that includes tuna steaks, mackerel, salmon, sardines, bluefish, and swordfish. Positive associations between toenail arsenic and consumption of white wine, beer, and Brussels sprouts were also observed; these and most other associations were not modified by exposure via water. However, consumption of two foods cooked in water, beans/lentils and cooked oatmeal, was more strongly related to toenail arsenic among those with arsenic-containing drinking water (≥1 µg/L). CONCLUSIONS: This study suggests that diet can be an important contributor to total arsenic exposure in U.S. populations regardless of arsenic concentrations in drinking water. Thus, dietary exposure to arsenic in the US warrants consideration as a potential health risk.


Subject(s)
Arsenic/analysis , Carcinogens, Environmental/analysis , Drinking Water/chemistry , Food Contamination , Models, Biological , Nails/chemistry , Water Pollution, Chemical/adverse effects , Adult , Aged , Arsenic/administration & dosage , Arsenic/metabolism , Arsenic/toxicity , Biomarkers/analysis , Biomarkers/metabolism , Carcinogens, Environmental/administration & dosage , Carcinogens, Environmental/metabolism , Carcinogens, Environmental/toxicity , Case-Control Studies , Diet/adverse effects , Drinking Water/adverse effects , Female , Humans , Male , Middle Aged , Nails/metabolism , New Hampshire , Skin Neoplasms/chemically induced , Skin Neoplasms/metabolism , Toes , Urinary Bladder Neoplasms/chemically induced , Urinary Bladder Neoplasms/metabolism , Water Supply/analysis , Young Adult
8.
Nutr J ; 11: 45, 2012 Jun 29.
Article in English | MEDLINE | ID: mdl-22747713

ABSTRACT

BACKGROUND: Dietary factors such as folate, vitamin B12, protein, and methionine are important for the excretion of arsenic via one-carbon metabolism in undernourished populations exposed to high levels of arsenic via drinking water. However, the effects of dietary factors on toenail arsenic concentrations in well-nourished populations exposed to relatively low levels of water arsenic are unknown. METHODS: As part of a population-based case-control study of skin and bladder cancer from the USA, we evaluated relationships between consumption of dietary factors and arsenic concentrations in toenail clippings. Consumption of each dietary factor was determined from a validated food frequency questionnaire. We used general linear models to examine the associations between toenail arsenic and each dietary factor, taking into account potentially confounding effects. RESULTS: As expected, we found an inverse association between ln-transformed toenail arsenic and consumption of vitamin B12 (excluding supplements) and animal protein. Unexpectedly, there were also inverse associations with numerous dietary lipids (e.g., total fat, total animal fat, total vegetable fat, total monounsaturated fat, total polyunsaturated fat, and total saturated fat). Finally, increased toenail arsenic concentrations were associated with increased consumption of long chain n-3 fatty acids. CONCLUSION: In a relatively well-nourished population exposed to relatively low levels of arsenic via water, consumption of certain dietary lipids may decrease toenail arsenic concentration, while long chain n-3 fatty acids may increase toenail arsenic concentration, possibly due to their association with arsenolipids in fish tissue.


Subject(s)
Arsenic/analysis , Diet , Nails/chemistry , Water Wells/chemistry , Aged , Case-Control Studies , Dietary Fats/analysis , Docosahexaenoic Acids/analysis , Drinking Water/chemistry , Eicosapentaenoic Acid/analysis , Environmental Exposure , Female , Fish Oils/analysis , Folic Acid/analysis , Humans , Male , Methionine/analysis , Middle Aged , New Hampshire , Regression Analysis , Surveys and Questionnaires , Urinary Bladder Neoplasms/physiopathology , Vitamin B 12/analysis
9.
Clin Cancer Res ; 16(5): 1682-9, 2010 Mar 01.
Article in English | MEDLINE | ID: mdl-20179218

ABSTRACT

PURPOSE: Epigenetic alterations including changes to cellular DNA methylation levels contribute to carcinogenesis and may serve as powerful biomarkers of the disease. This investigation sought to determine whether hypomethylation at the long interspersed nuclear elements (LINE1), reflective of the level of global DNA methylation, in peripheral blood-derived DNA is associated with increased risk of bladder cancer. EXPERIMENTAL DESIGN: LINE1 methylation was measured from blood-derived DNA obtained from participants of a population-based incident case-control study of bladder cancer in New Hampshire. Bisulfite-modified DNA was pyrosequenced to determine LINE1 methylation status; a total of 285 cases and 465 controls were evaluated for methylation. RESULTS: Being in the lowest LINE1 methylation decile was associated with a 1.8-fold increased risk of bladder cancer [95% confidence interval (95% CI), 1.12-2.90] in models controlling for gender, age, and smoking, and the association was stronger in women than in men (odds ratio, 2.48; 95% CI, 1.19-5.17 in women; and odds ratio, 1.47; 95% CI, 0.79-2.74 in men). Among controls, women were more likely to have lower LINE1 methylation than men (P = 0.04), and levels of arsenic in the 90th percentile were associated with reduced LINE1 methylation (P = 0.04). CONCLUSIONS: LINE1 hypomethylation may be an important biomarker of bladder cancer risk, especially among women.


Subject(s)
Biomarkers, Tumor/genetics , DNA Methylation , Long Interspersed Nucleotide Elements/genetics , Urinary Bladder Neoplasms/genetics , Adult , Aged , Female , Genetic Predisposition to Disease/genetics , Humans , Male , Middle Aged , Risk Factors
10.
J Urol ; 178(4 Pt 1): 1196-200; discussion 1200, 2007 Oct.
Article in English | MEDLINE | ID: mdl-17698105

ABSTRACT

PURPOSE: The WHO/International Society of Urological Pathology classification of bladder cancer, introduced in 1998, differs from the traditional 1973 WHO classification. Few studies have reported survival data based on the WHO/International Society of Urological Pathology classification and none has demonstrated clear superiority compared to the 1973 WHO system. In a large, nonselected population of patients with bladder cancer we rated all incident tumors using each system and compared long-term patient survival. MATERIALS AND METHODS: New Hampshire residents with bladder cancer diagnosed between 1994 and 2000 were identified through the State Cancer Registry. Slides were retrieved from more than 90% of cases and reviewed by a single pathologist. Tumors were classified according to WHO and WHO/International Society of Urological Pathology criteria. Overall patient survival was determined for the cohort of 504 patients after an average of 7 years using a national mortality database. RESULTS: For both grading systems there was a gradient of progressively lower survival times from the lowest grade to the highest grade tumors. Hazard ratios and 95% confidence intervals for the WHO/International Society of Urological Pathology system were 1.9 (1.0-3.4) for low grade papillary urothelial carcinoma and 3.0 (1.5-6.0) for high grade papillary urothelial carcinoma, compared to papillary urothelial neoplasms of low malignant potential. For the WHO (1973) system compared to grade 1 tumors the hazard ratio for grade 2 tumors was 1.8 (1.1-3.1) and for grade 3 was 2.4 (1.2-4.7). CONCLUSIONS: Advantages of the WHO/International Society of Urological Pathology bladder tumor classification include more detailed diagnostic criteria, the ability to define a lesion with minimal malignant potential and the ability to identify a larger group of patients needing closer surveillance. However, we found that the WHO/International Society of Urological Pathology tumor categories did not detect a clear overall survival advantage compared to the WHO (1973) classification system.


Subject(s)
Carcinoma, Transitional Cell/pathology , Urinary Bladder Neoplasms/pathology , Aged , Carcinoma, Transitional Cell/diagnosis , Carcinoma, Transitional Cell/mortality , Cohort Studies , Female , Humans , Male , Middle Aged , Neoplasm Invasiveness/pathology , New Hampshire , Prognosis , Proportional Hazards Models , Registries , Survival Analysis , Urinary Bladder/pathology , Urinary Bladder Neoplasms/diagnosis , Urinary Bladder Neoplasms/mortality
SELECTION OF CITATIONS
SEARCH DETAIL
...